164 related articles for article (PubMed ID: 34348724)
1. Long-term prognostic outcomes in patients with haemoptysis.
Mondoni M; Carlucci P; Cipolla G; Pagani M; Tursi F; Fois A; Pirina P; Canu S; Gasparini S; Bonifazi M; Marani S; Comel A; Saderi L; De Pascalis S; Alfano F; Centanni S; Sotgiu G
Respir Res; 2021 Aug; 22(1):219. PubMed ID: 34348724
[TBL] [Abstract][Full Text] [Related]
2. Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative database.
Abdulmalak C; Cottenet J; Beltramo G; Georges M; Camus P; Bonniaud P; Quantin C
Eur Respir J; 2015 Aug; 46(2):503-11. PubMed ID: 26022949
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet or anticoagulant therapy might not increase the risk of haemoptysis in patients with bronchiectasis.
Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
Int J Tuberc Lung Dis; 2013 Jul; 17(7):989-91. PubMed ID: 23651792
[TBL] [Abstract][Full Text] [Related]
4. Haemoptysis: aetiology, evaluation and outcome--a prospective study in a third-world country.
Abal AT; Nair PC; Cherian J
Respir Med; 2001 Jul; 95(7):548-52. PubMed ID: 11453310
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Hemoptysis without Bronchiectasis or Cardiac Disease: Etiology, Recurrence, and Mortality.
Chiel L; Welsh S; Andren K; Mecklosky J; Alexander PMA; Casey A; Fishman MP
J Pediatr; 2019 Nov; 214():66-70. PubMed ID: 31540762
[TBL] [Abstract][Full Text] [Related]
6. Cause, treatment and outcome of patients with life-threatening haemoptysis.
Stebbings AE; Lim TK
Singapore Med J; 1999 Feb; 40(2):67-9. PubMed ID: 10414159
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for haemoptysis after percutaneous transthoracic needle biopsies in 4,172 cases: Focusing on the effects of enlarged main pulmonary artery diameter.
Hwang EJ; Park CM; Yoon SH; Lim HJ; Goo JM
Eur Radiol; 2018 Apr; 28(4):1410-1419. PubMed ID: 29063253
[TBL] [Abstract][Full Text] [Related]
8. Haemoptysis due to chronic tuberculosis vs. bronchiectasis: comparison of long-term outcome of arterial embolisation.
Lee JH; Kwon SY; Yoon HI; Yoon CJ; Lee KW; Kang SG; Lee CT
Int J Tuberc Lung Dis; 2007 Jul; 11(7):781-7. PubMed ID: 17609054
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with long-term haemoptysis recurrence after transarterial embolisation for haemoptysis.
Li Y; Jia Z; Li S; Huang Y; Yuan X; Chen W
Int J Tuberc Lung Dis; 2020 Jun; 24(6):606-611. PubMed ID: 32553004
[No Abstract] [Full Text] [Related]
10. An integrated approach to diagnosis and management of severe haemoptysis in patients admitted to the intensive care unit: a case series from a referral centre.
Fartoukh M; Khalil A; Louis L; Carette MF; Bazelly B; Cadranel J; Mayaud C; Parrot A
Respir Res; 2007 Feb; 8(1):11. PubMed ID: 17302979
[TBL] [Abstract][Full Text] [Related]
11. Bronchial artery embolization for massive hemoptysis: long-term follow-up.
Fruchter O; Schneer S; Rusanov V; Belenky A; Kramer MR
Asian Cardiovasc Thorac Ann; 2015 Jan; 23(1):55-60. PubMed ID: 25053662
[TBL] [Abstract][Full Text] [Related]
12. [Life-threatening hemoptysis: study of 154 patients].
Orriols R; Núñez V; Hernando R; Drobnic E; Moreiras M
Med Clin (Barc); 2012 Sep; 139(6):255-60. PubMed ID: 22704276
[TBL] [Abstract][Full Text] [Related]
13. Dilemma on the treatment of haemoptysis: an analysis of 249 patients.
Tunçözgür B; Işik AF; Nacak I; Akar E; Elbeyli L
Acta Chir Belg; 2007 Jun; 107(3):302-6. PubMed ID: 17685258
[TBL] [Abstract][Full Text] [Related]
14. Management of life-threatening haemoptysis in an area of high tuberculosis incidence.
Gross AM; Diacon AH; van den Heuvel MM; Janse van Rensburg J; Harris D; Bolliger CT
Int J Tuberc Lung Dis; 2009 Jul; 13(7):875-80. PubMed ID: 19555538
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
[TBL] [Abstract][Full Text] [Related]
16. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
[TBL] [Abstract][Full Text] [Related]
17. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behçet's syndrome patients with pulmonary artery involvement during follow-up.
Esatoglu SN; Seyahi E; Ugurlu S; Gulsen F; Akman C; Cantasdemir M; Numan F; Tuzun H; Melikoglu M; Yazici H; Hamuryudan V
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):92-96. PubMed ID: 27791952
[TBL] [Abstract][Full Text] [Related]
18. [Severe haemoptysis: indications for triage and admission to hospital or intensive care unit].
Fartoukh M
Rev Mal Respir; 2010 Dec; 27(10):1243-53. PubMed ID: 21163400
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: optimal management of patients on antiplatelet therapy.
Okano A; Oya S; Fujisawa N; Tsuchiya T; Indo M; Nakamura T; Chang HS; Matsui T
Br J Neurosurg; 2014 Apr; 28(2):204-8. PubMed ID: 23952136
[TBL] [Abstract][Full Text] [Related]
20. [Haemoptysis : Intensive care management of pulmonary hemorrhage].
Ficker JH; Brückl WM; Suc J; Geise A
Internist (Berl); 2017 Mar; 58(3):218-225. PubMed ID: 28138763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
